Madam Chair, it is exciting that we have access now to the Eli Lilly drug, which has been approved by Health Canada and, indeed, the FDA. I will say it is a Canadian success story because, in fact, AbCellera, the company here in Canada, was the creator of this novel drug that helps lessen severe cases of COVID-19.
In the House of Commons on November 26th, 2020. See this statement in context.